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In this issue, a pair of studies (Levy et al. and Sanders et al.) identify several de novo copy-number variants that
together account for 5%–8%ofcasesof simplexautismspectrumdisorders. Thesestudiessuggest that several
hundreds of loci are likely to contribute to the complex genetic heterogeneity of this group of disorders. An
accompanying study in this issue (Gilman et al.), presents network analysis implicating these CNVs in neural
processes related to synapse development, axon targeting, and neuron motility.Autism spectrum disorders (ASDs) are
among the most common neuropsychi-
atric disorders, with an estimated world-
wide prevalence of 1%–2.6% (Kogan
et al., 2009; Kim et al., 2011). Almost 70
years after the description of autism by
Leo Kanner and Hans Asperger, tremen-
dous progress has been made in the
recognition and diagnosis of children
with ASDs. It is well established that
ASDs represent a heterogeneous group
of disorders that are highly heritable, with
heritability indices estimated at 85%–
92%. Advances in identifying the genetic
causes of ASDs first came from the study
of syndromic autism (ASDs in conjunction
with congenital malformations and/or
dysmorphic features), which pinpointed
the causes of disorders, such as fragile
X syndrome, Rett syndrome, PTEN mac-
rocephaly syndrome, Timothy syndrome,
and Joubert syndrome, to name a few
(Miles, 2011). The challenge, however,
was identifying the genetic cause of
nonsyndromic or idiopathic autism given
the lack of defining features besides the
neurobehavioral phenotypes and the
fact that the majority of cases were
simplex (one affected in a family). This
issue of Neuron highlights three studies
of simplex, mostly nonsyndromic, rela-
tively high-functioning ASDs (Levy et al.,
2011; Sanders et al., 2011; Gilman et al.,
2011), that establish de novo copy-
number variants (CNVs) as the cause of
5%–8% of cases of simplex autism.
Copy-Number Variants and ASD
Using different array platforms on practi-
cally the same cohort of patients, both806 Neuron 70, June 9, 2011 ª2011 ElsevierSanders et al. (2011) and Levy et al.
(2011) confirmed the role of de novo
CNVs in the etiology of idiopathic autism.
The analysis of a large number of families
from the Simons Simplex Collection
(SSC)—887 families in the Levy paper
and 1174 families in the Sanders paper—
allows them to confirm multiple known
ASD loci but also to identify novel loci,
such as 16p13.2 and the CDH13 locus.
The sheer number of different de novo
CNVs identified in the probands, but not
their unaffected siblings, supports the
conclusion that autism is mostly caused
by rare mutations (at least for CNVs that
is), withmost de novo events being unique
to each proband.
As previously established, and now
confirmed in larger data sets, deletions
and duplications of 16p11.2 are the single
most common cause of ASDs identifiable
by DNA array analysis. This is the only
locus known to date that accounts
for > 1% of ASD cases, i.e., 1.1%–1.2%,
with deletions being slightly more
common than duplications. Given the
relatively large number of individuals with
CNVs identified in these studies, it would
have been interesting to learn of any geno-
type-phenotype correlations, but none
were reported except for body mass
index, which negatively correlates with
copy number at the 16p11.2 locus.
It is quite interesting that both studies
revealed the importance of 7q11.23 as an
ASD locus. While deletions of this region
cause Williams syndrome, a multiple
congenital anomaly syndrome with hyper-
sociable behaviors, duplications of the
same region cause ASDs. The opposingInc.social phenotypes of 7p11.23 deletions
and duplications provide a fascinating
basis for studies in animal models to
pinpoint the genes and neuronsmediating
these phenotypes. Within the genomic
region, CLIP2, LIMK1, GTF2i, and STX1A
have been proposed as potential culprit
genes, but the exact underlying pathome-
chanisms are far from being understood.
The Diverse Genetic Causes
of ASDs
While the high heritability of autism is well
established, the exact underlying causes
and mutations are identifiable only in
a minority of patients. Using current clin-
ical DNA arrays, relevant de novo
genomic imbalances can be identified in
7%–20% of individuals with autism of
unknown cause. As expected, the yield
is higher in those individuals with ‘‘syn-
dromic’’ autism. Known single-gene
disorders account for another 5%–7% of
cases, with fragile X syndrome being
the most common (1%–3% of cases), fol-
lowed by PTENmacrocephaly syndrome,
tuberous sclerosis complex, and Rett
syndrome (each accounting for approxi-
mately 1% of children diagnosed with
autism) (Miles, 2011). Timothy syndrome,
Joubert syndrome, SHANK3 mutations,
NRXN1 mutations, and a handful of other
genes account for rare cases. There
remain large cohorts of patients that
have to be screened for the incidence of
respective point mutations and their
contribution to the overall number of
autism cases. Lastly, several metabolic
conditions have been associated with
ASDs, including mitochondrial disorders,
Figure 1. Genetic Causes of Autism Spectrum
Disorders
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Previewsphenylketonuria, adenylosuccinate
lyase deficiency, creatine defi-
ciency, and some disorders of sterol
biosynthesis. In total, known meta-
bolic disorders may account for
approximately 5% of cases of
ASDs. This leaves us with at least
70% of cases, for which the genetic
cause of ASDs cannot yet be identi-
fied (Figure 1). The percentage is
even higher for the nonsyndromic
cases of ASDs.
One would have hoped that the
type of detailed analysis of large
ASD cohorts using very high-resolu-
tion arrays as those used in theSanders and Levy studies would have
yielded a high number of identifiable
mutations, yet the results are humbling.
There is no remarkable increase in pickup
rate of CNVs, despite much increased
density when compared to previous
studies, pointing to the limitations of array
analysis and the contributions of de novo
and rare inherited CNVs to the etiology of
ASDs overall. There is hope that whole-
exome and whole-genome sequencing
will fill the gap and identify coding variants
causing autism, some of which may be in
genes involved in CNVs already associ-
ated with ASDs and others of which will
be in novel ASD susceptibility genes.
The total number of ASD genes and target
loci is estimated at 250–400 by Levy et al.
(2011) and around 130 by Sanders et al.
(2011). However, both of these are calcu-
lations based only on existing CNV data.
The actual number of autism suscepti-
bility genes may be very different, de-
pending on what the large-scale se-
quencing studies reveal. The number of
genes, mutations of which account for
themajority of ASD casesmay be as small
as a dozen or two, but may also be in the
thousands.
Mutational Mechanisms
Contributing to ASDs
Different mutational mechanisms have
been shown to contribute to ASDs,
including de novo and inherited CNVs,
as well as de novo and inherited point
mutations. As shown for 16p11.2 dele-
tions and duplications, specific mutations
manifest variable expressivity and incom-
plete penetrance, even within the same
family. These phenomena are applicable
to neuropsychiatric disorders in general(Sebat et al., 2009). What is unique about
ASDs is the male predominance of
the phenotype, with an overall 4:1 male-
to-female sex ratio. Why this is the case
remains unknown. Sanders et al. (2011)
state that based on their data there is
no evidence for a causal role of rare
X-chromosomal CNVs accounting for
this sex ratio. Levy et al. (2011) found
that females with ASDs have a higher
frequency of de novo CNVs when
compared to males; furthermore, they
found more genes to be present in events
from female probands than in those from
male probands. They speculate that
females have greater resistance to autism
from genetic causes. This idea is sup-
ported by the companion paper by Gil-
man et al. (2011), who describe a large
biological network of genes affected by
rare de novoCNVs and showconvincingly
that stronger functional perturbations are
required to trigger the autistic phenotype
in females compared to males. Given
these findings, what accounts for the
female resistance to autism? Earlier this
year, it was proposed that sex hormonal
expression patterns may account for at
least part of that, as androgens and
estrogens differentially and reciprocally
regulate RORA, a novel candidate gene
for autism (Sarachana et al., 2011).
Genetic modifiers may also account for
a sex bias. Several autism-causing genes
are located on the X chromosome (FMR1,
NLGN4X, MECP2, etc.). Hypomorphic
variants of such genes, which do not
manifest a phenotype per se, might still
alter the individual’s overall penetrance
of autistic traits. Their presence in hemi-
zygosity in males would lead to a stronger
effect than in females.Neuron 70, JLevy et al. (2011) conclude that
‘‘the hypothesis that autism results
from an unfortunate combination
of common low-risk variants can
be safely rejected.’’ This conclusion
seems premature, especially given
that it is based solely on CNV
data, while large-scale sequencing
data on large cohorts of autistic
individuals are still being collected.
Sequencing studies on individuals
with ASDs support a multihit model
for disease risk (O’Roak et al.,
2011) and a model of oligogenic
heterozygosity has been proposed,
especially for individuals with high-functioning ASDs (Schaaf et al., 2011).
Considering that de novo CNVs are more
commonly detected in simplex cases of
ASDs when compared to familial cases of
ASDs, one could envision that oligogenic
and complex patterns of inheritance may
play a more important role in families with
multiple individuals affected with ASDs.
Several hypomorphic variants may
accumulate either in a specific signaling
pathway or in a subcellular compartment
(such as the synapse) to exceed a
threshold and result in phenotypic mani-
festation. This would be consistent with
data fromclinical studieswherebychildren
from families in which both parents mani-
fest subthreshold autistic traits are more
likely to show more severe impairment in
reciprocal and social behavior (Constan-
tino and Todd, 2005).
Functional Considerations
The study presented by Gilman et al.
(2011) widens the perspective from sheer
identification of CNVs to a more func-
tional interpretation. They identify a large
biological network of genes affected by
rare de novo CNVs. This can be seen as
a proof of principle that networks under-
lying complex human phenotypes can
be identified by a network-based func-
tional analysis of rare genetic variants.
Most importantly, the network links
molecules to biological functions and
cellular compartments, i.e., synaptogene-
sis, axon guidance, and neuronal motility.
Several signaling pathways important in
the regulation of dendrite morphogenesis
stand out as core elements of the overall
network, including the WNT pathway,
the reelin pathway, the mTOR pathway,
and the Rho/LINK1 pathway. Using anune 9, 2011 ª2011 Elsevier Inc. 807
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Previewsexperimental approach Sakai et al.
recently identified a protein interaction
network, functionally connecting hun-
dreds of proteins to known and novel
ASD proteins. In particular, they exempli-
fied how a protein interaction network
based on proteins primarily associated
with syndromic autism can be used to
identify causative mutations in individuals
with nonsyndromic autism (Sakai et al.,
2011). This suggests a significant overlap
in the genetics of syndromic and nonsyn-
dromic autism.
The identification of key molecular
pathways that link many ASD-causing
genes is of utmost importance when it
comes to potential therapeutic interven-
tions. It is very likely that there will be
hundreds of autism genes and proteins;
thus designing treatments for ASDs
tackling one gene at a time will be a
challenge. Identifying functional relation-
ships and interactions between various
ASD-associated proteins is likely to
identify signaling pathways and subcel-
lular compartments that encompass
a whole subgroup of such genes. Having
such rich functional pathway information808 Neuron 70, June 9, 2011 ª2011 Elseviermight unearth common targets that are
amenable to therapy.
This is a very exciting time for autism
research. Large, thoroughly phenotyped
cohorts and collections of biospecimens
are available. Many ASD loci and genes
have been identified and are just begin-
ning to be connected in functional
networks. While we are awaiting the
results of multiple large-scale sequencing
efforts, the field is poised to move on to
functional studies that will help under-
stand the molecular underpinnings and
neural substrates of this disorder in
hopes of developing more effective
interventions.REFERENCES
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Vascular endothelial growth factor (VEGF) family members are best known for their powerful mitotic and
angiogenic activities toward endothelial cells. Two independent studies in this issue of Neuron now provide
compelling evidence that VEGF-A secreted at the CNS midline functions as an attractant for developing
axons of spinal commissural neurons and contralaterally projecting retinal ganglion cells.The assembly of a highly organized
network of neuronal connections is a key
developmental process and essential for
all neural function, ranging from simple
movement to complex cognitive pro-
cesses. Research focused on the cellular
strategies and molecular mechanismsthat orchestrate neural network assembly
led to the discovery of a wide variety of
axon guidance molecules and receptors
(Kolodkin and Tessier-Lavigne, 2010).
Many guidance molecules are evolution-
arily conserved and, based on their
mode of action, are categorized intoshort- or long-range guidance cues that
influence growth cone steering in a posi-
tive (attractive) or negative (repulsive/
inhibitory) manner. We now know that
the activity of an individual guidance cue
is not absolute, but instead interpreted
by the neuronal growth cone in a
